News

[PRESS RELEASE] GE heatlthcare announces first patient dosed in phase III clinical trial for new dopamine transporter imaging radiopharmaceutical

Dates

from April 10, 2022 to May 1, 2022

Contact :
Maria-Joao Santiago-Ribeiro :